References
I. Cakir, K. Unluhizarci, F. Tanriverdi, G. Elbuken, Z. Karaca, F. Kelestimur. Investigation of insulin resistance in patients with normocalcemic primary hyperparathyroidism. Endocrine (2012). [Epub ahead of print]
L. Rejnmark, P. Vestergaard, C. Brot, L. Mosekilde, Increased fracture risk in normocalcemic postmenopausal women with high parathyroid hormone levels: a 16-year follow-up study. Calcif. Tissue Int. 88, 238–245 (2011)
S.J. Silverberg, E.M. Lewiecki, L. Mosekilde, M. Peacock, M.R. Rubin, Presentation of asymptomatic primary hyperparathyroidism: proceeding of the third international workshop. J. Clin. Endocrinol. Metab. 94, 351–365 (2009)
Conflicts of interest
No potential conflicts of interest relevant to this article were reported.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
García-Martín, A., Reyes-García, R. & Muñoz-Torres, M. Normocalcemic primary hyperparathyroidism: one-year follow-up in one hundred postmenopausal women. Endocrine 42, 764–766 (2012). https://doi.org/10.1007/s12020-012-9694-z
Published:
Issue Date:
DOI: https://doi.org/10.1007/s12020-012-9694-z